Sukurti paskyrą
Verslo klientas Fizinis asmuo

Registruokitės dabar ir naudokitės privalumais
  • Asmeniniai kainų pasiūlymai
  • Pristatymo sekimas
  • Greitas atsiskaitymas
  • Užsakymų istorija
  • Matomas prekių kiekis sandėlyje
Cart

Your cart is empty, just add some products

This is a fantastic opportunity to fill the cart with something really special!

Estimated shipping

0,00 €

Total: 0,00 €

nova@novabio.lt image/svg+xml 370 (620) 70159
ET EN
image/svg+xml Prisijungti / Registruotis
Prisijunkite arba registruokitės
Prisijungti Sukurti paskyrą
Registruokitės dabar ir naudokitės privalumais
  • Asmeniniai kainų pasiūlymai
  • Pristatymo sekimas
  • Greitas atsiskaitymas
  • Užsakymų istorija
  • Matomas prekių kiekis sandėlyje
Cart (0) ET EN
UNCHAINED

Upcoming Unchained Labs webinars

rugs. 02, 2024

3 min

1) "Preventing the danger of unwanted CAR expression during lentivirus production"
Sept 5, 2024, 18:00 (EET)

Join this exclusive webinar to discover advanced strategies for enhancing the quality of lentiviral (LV) vectors in cell therapy manufacturing. This webinar will showcase the Leprechaun platform from Unchained Labs, which promises precise identification and monitoring of CAR expression on the LV surface.

Key takeaways include:

  • Preventing breakthrough expression: Comprehend why preventing breakthrough transgene expression is critical for the safety and efficacy of your cell therapy.
  • Optimizing LV performance: Understand how Lentitek’s system can help prevent unwanted transgene expression.
  • Comprehensive quality monitoring: Learn how Leprechaun helps you monitor breakthrough expression by measuring the titer of LV with transgene protein on the surface straight from harvest.

Register HERE

2) "Addressing the challenge of screening DNA-LNP formulations for targeting the brain"
Sept 12, 2024, 18:00 (EET)

In this webinar, Razieh Karamzadeh will present data from experiments conducted at Karolinska Institute using Unchained Labs’ Sunscreen and Sunshine systems for production of DNA-LNPs for in vitro screening, then scaling-up selected LNPs for in vivo studies.

Key Takeaways:

  • The challenges of targeted delivery of LNPs
  • The key benefit of high-throughput screening for improving extra-hepatic delivery
  • The benefit of consistent particle production at different volume scales

Register HERE


Share

Contact

Nova Natura UAB

Kaštonų g. 56, Giraitės k, LT-54310,
Kaunas, Lithuania

nova@novabio.lt
Phone: +370 (620) 70159

Reg No 305063819

Nova Natura OÜ

Valukoja 8, 11415,
Tallinn, Estonia

nova@novabio.ee
Phone: +372 5656 0050

Reg No 14758203

Kontaktai

Other

Naujienlaiškio prenumerata

Prisijunkite prie mūsų naujienlaiškio!
ISO9001 1 e1593687280362
©Nova natura